Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Ranolazine for the Treatment of Amyotrophic Lateral Sclerosis

NCT03472950 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.

NCT NCT03472950
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03472950 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Ranolazine for the Treatment of Amyotrophic Lateral Sclerosis
Lead sponsor
University of Kansas Medical Center
Phase
Phase 2
Overall status
Completed
Start date
June 11, 2018
Completion date
December 9, 2022
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

als